Cargando…

The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth

ABC294640 is a specific sphingosine kinase 2 (SphK2) inhibitor. The anti-cervical carcinoma activity by ABC294640 was tested in this study. ABC294640 inhibited in vitro growth of the established (C33A and HeLa lines) and primary human cervical carcinoma cells. The SphK2 inhibitor also induced G1-S a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ling, Jin, Longmei, Yang, Baohua, Wang, Lifeng, Xia, Ziyin, Zhang, Qian, Xu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788647/ https://www.ncbi.nlm.nih.gov/pubmed/29416779 http://dx.doi.org/10.18632/oncotarget.23415

Ejemplares similares

Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
por: Dai, Lu, et al.
Publicado: (2020)

Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo
por: Song, Keqi, et al.
Publicado: (2019)

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
por: Ding, Xiwei, et al.
Publicado: (2016)

Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
por: Xun, Cai, et al.
Publicado: (2015)

Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640
por: Lewis, Clayton S., et al.
Publicado: (2016)

Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
por: McNaughton, Melissa, et al.
Publicado: (2016)

Sphingosine kinase 2 inhibitor ABC294640 suppresses neuronal excitability and inhibits multiple endogenously and exogenously expressed voltage-gated ion channels in cultured cells
por: Zhang, Fei, et al.
Publicado: (2020)

The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl‐2 inhibitor (ABT‐199) displays synergistic anti‐myeloma effects in myeloma cells without a t(11;14) translocation
por: Sundaramoorthy, Pasupathi, et al.
Publicado: (2018)

The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein
por: Grbčić, Petra, et al.
Publicado: (2021)

The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth
por: Zhang, Yan, et al.
Publicado: (2022)

LncRNA BBOX1‐AS1 upregulates HOXC6 expression through miR‐361‐3p and HuR to drive cervical cancer progression
por: Xu, Jun, et al.
Publicado: (2020)

Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition
por: Bennett, Melissa K., et al.
Publicado: (2021)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
por: Gao, Peng, et al.
Publicado: (2012)

Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival
por: Olivera, Ana, et al.
Publicado: (1999)

Drugging Sphingosine Kinases
por: Santos, Webster L., et al.
Publicado: (2014)

The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V
por: Sun, Xu, et al.
Publicado: (2022)

Structure–Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
por: Baek, Dong Jae, et al.
Publicado: (2013)

Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
por: Tanaka, Yuko, et al.
Publicado: (2022)

Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression
por: Xu, Yunze, et al.
Publicado: (2015)

Sphingosine kinase 1 expression enhances colon tumor growth
por: Furuya, Hideki, et al.
Publicado: (2017)

A Novel Sphingosine Kinase Inhibitor Suppresses Chikungunya Virus Infection
por: Oyewole, Opeoluwa O., et al.
Publicado: (2022)

Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management
por: Barnawi, Jameel
Publicado: (2023)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression
por: Zhu, Yunheng, et al.
Publicado: (2020)

Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice
por: Chen, Jinbiao, et al.
Publicado: (2018)

SLC5A3 is important for cervical cancer cell growth
por: Li, Li, et al.
Publicado: (2023)

Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis
por: Snider, Ashley J., et al.
Publicado: (2013)

Sphingosine Kinases/Sphingosine-1-Phosphate and Death Signalling in APP-Transfected Cells
por: Gassowska, Magdalena, et al.
Publicado: (2014)

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina
por: Porter, Hunter, et al.
Publicado: (2018)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways
por: Ishay, Yuval, et al.
Publicado: (2021)

Role of Sphingosine Kinase in Type 2 Diabetes Mellitus
por: Qi, Yanfei, et al.
Publicado: (2021)

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
por: Imbert, Caroline, et al.
Publicado: (2020)

Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
por: Khan, Faez Iqbal, et al.
Publicado: (2019)

Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
por: Shrestha, Jitendra, et al.
Publicado: (2022)

An oncogenic role for sphingosine kinase 2
por: Neubauer, Heidi A., et al.
Publicado: (2016)

Sphingosine kinase 2 and multiple myeloma
por: Pyne, Nigel J., et al.
Publicado: (2017)

Transcriptional Regulation of Sphingosine Kinase 1
por: Bonica, Joseph, et al.
Publicado: (2020)

The Functional Role of Sphingosine Kinase 2
por: Diaz Escarcega, Rocio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o9cql373a2u8c9s34oee67ndq